How Can We Mitigate the Risks Associated with Pluripotent Stem Cells?
Several strategies are being explored to mitigate the risks. One approach involves rigorous screening of iPSCs for genetic and epigenetic abnormalities before their use in therapy. Additionally, advances in gene-editing technologies like CRISPR-Cas9 offer the potential to correct any mutations that might lead to cancer.
